Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8915
|
pubmed:dateCreated |
1994-7-28
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
344
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
114-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
1994
|
pubmed:articleTitle |
What is the rationale for growth hormone therapy in Turner's syndrome?
|
pubmed:affiliation |
Department of Paediatric, Tor Vergata University, Rome, Italy.
|
pubmed:publicationType |
Journal Article
|